Astrid Slany, Jürgen Zezula, Karoline Fuchs, Werner Sieghart
{"title":"Allosteric modulation of [3H]flunitrazepam binding to recombinant GABAA receptors","authors":"Astrid Slany, Jürgen Zezula, Karoline Fuchs, Werner Sieghart","doi":"10.1016/0922-4106(95)90130-2","DOIUrl":null,"url":null,"abstract":"<div><p>The allosteric modulation of [<sup>3</sup>H]flunitrazepam binding by γ-aminobutyric acid (GABA), pentobarbital, (+)-etomidate, etazolate, alphaxalone, propofol and chlormethiazole was investigated in cerebellar membranes from human embryonic kidney (HEK) 293 cells transfected with α<sub>1</sub>β<sub>3</sub>γ<sub>2</sub> or α<sub>1</sub>γ<sub>2</sub> subunits. Results obtained indicate that [<sup>3</sup>H]flunitrazepam binding to recombinant GABA<sub>A</sub> receptors consisting of α<sub>1</sub>β<sub>3</sub>γ<sub>2</sub> subunits could be modulated by these compounds in a way and with a potency similar to that observed in cerebellar membranes. In addition, it was demonstrated that not only receptors consisting of α<sub>1</sub>β<sub>3</sub>γ<sub>2</sub>, but also those consisting of α<sub>1</sub>γ<sub>2</sub> subunits exhibited [<sup>3</sup>H]flunitrazepam binding which could be stimulated by GABA. In contrast to α<sub>1</sub>β<sub>3</sub>γ<sub>2</sub> receptors, however, [<sup>3</sup>H]flunitrazepam binding to recombinant α<sub>1</sub>γ<sub>2</sub> receptors was inhibited by pentobarbital, (+)-etomidate, etazolate, alphaxalone, propofol and chlormethiazole. This seems to indicate that binding sites for these compounds are present on α<sub>1</sub>γ<sub>2</sub> receptors, but that their allosteric interaction with [<sup>3</sup>H]flunitrazepam binding sites is different from that of α<sub>1</sub>β<sub>3</sub>γ<sub>2</sub> receptors.</p></div>","PeriodicalId":100502,"journal":{"name":"European Journal of Pharmacology: Molecular Pharmacology","volume":"291 2","pages":"Pages 99-105"},"PeriodicalIF":0.0000,"publicationDate":"1995-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0922-4106(95)90130-2","citationCount":"26","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmacology: Molecular Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0922410695901302","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 26
Abstract
The allosteric modulation of [3H]flunitrazepam binding by γ-aminobutyric acid (GABA), pentobarbital, (+)-etomidate, etazolate, alphaxalone, propofol and chlormethiazole was investigated in cerebellar membranes from human embryonic kidney (HEK) 293 cells transfected with α1β3γ2 or α1γ2 subunits. Results obtained indicate that [3H]flunitrazepam binding to recombinant GABAA receptors consisting of α1β3γ2 subunits could be modulated by these compounds in a way and with a potency similar to that observed in cerebellar membranes. In addition, it was demonstrated that not only receptors consisting of α1β3γ2, but also those consisting of α1γ2 subunits exhibited [3H]flunitrazepam binding which could be stimulated by GABA. In contrast to α1β3γ2 receptors, however, [3H]flunitrazepam binding to recombinant α1γ2 receptors was inhibited by pentobarbital, (+)-etomidate, etazolate, alphaxalone, propofol and chlormethiazole. This seems to indicate that binding sites for these compounds are present on α1γ2 receptors, but that their allosteric interaction with [3H]flunitrazepam binding sites is different from that of α1β3γ2 receptors.